Home Biosimilar Antibodies Immunology & Inflammation CD markers Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) For research use only.
Not for use in humans.

Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134)

Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) is an agonistic antibody that recognizes the co-stimulatory receptor OX40 (CD134; TNFRSF4) with potential immunostimulatory activity. MW: 144.18 KD.

Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) is an agonistic antibody that recognizes the co-stimulatory receptor OX40 (CD134; TNFRSF4) with potential immunostimulatory activity. MW: 144.18 KD.

Product Details

CAS No. 2225940-98-5
Molecular Weight 144.18
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) | Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) supplier | purchase Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) | Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) cost | Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) manufacturer | order Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) | Ivuxolimab (Anti-TNFRSF4 / OX40 / CD134) distributor